Skip to main content
Premium Trial:

Request an Annual Quote

Agencourt to Distribute Lucigen s Products in North America

NEW YORK, May 27 - Agencourt Biosciences has signed an agreement with Lucigen, of Middleton, Wisc., to be the exclusive North American distributor of Lucigen's research products, the companies said today.


The products which Agencourt is to distribute include Lucigen's CloneSmart cloning kits, for the cloning of whole genomes or difficult-to-clone genes using low-background vectors, and related research products.


Under the agreement, Agencourt, of Beverly, Mass., will also gain rights to Lucigen's single cell genomics gene discovery libraries, in return for genomic sequencing services and undisclosed payments.


Separately, Agencourt said that it had hired two new sales representatives, Linda Ray, who was a New England sales rep for sequencing and genetic stability testing company SeqWright, and Linda Bean, formerly of Lark technologies.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.